Considering that COVID-19's cytokine storm presents with an elevation of IL-6, TNF-a, and IL-1ß and that pathophysiology of myalgia also involves these cytokines, it seems reasonable to associate SARS-CoV-2 infection with myalgia. Here, IL1B is linked to COVID-19.